Drug Shortage Report for CLADRIBINE INJECTION

Last updated on 2022-02-28 History
Report ID 147577
Drug Identification Number 02319918
Brand name CLADRIBINE INJECTION
Common or Proper name Cladribine Injection 1 mg/mL SD Vial 10 mL
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) CLADRIBINE
Strength(s) 1MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10 mL
ATC code L01BB
ATC description ANTIMETABOLITES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2021-11-17
Actual start date 2021-11-17
Estimated end date 2022-02-22
Actual end date 2022-02-22
Shortage status Resolved
Updated date 2022-02-28
Company comments Generic Medical Partners is an alternate supplier of Cladribine Injection and have been informed of our impending supply interruption.
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2022-02-28 French Compare
v12 2022-02-28 English Compare
v11 2022-02-08 French Compare
v10 2022-02-08 English Compare
v9 2021-12-24 French Compare
v8 2021-12-24 English Compare
v7 2021-11-18 French Compare
v6 2021-11-18 English Compare
v5 2021-11-18 English Compare
v4 2021-10-19 French Compare
v3 2021-10-19 English Compare
v2 2021-10-19 French Compare
v1 2021-10-19 English Compare

Showing 1 to 13 of 13